Interleukin-18 as a drug repositioning opportunity for inflammatory bowel disease: A Mendelian randomization study

MLA

Luke Devey, et al. Interleukin-18 as a Drug Repositioning Opportunity for Inflammatory Bowel Disease: A Mendelian Randomization Study. June 2019. EBSCOhost, https://doi.org/10.1038/s41598-019-45747-2.

APA

Luke Devey, Lon R. Cardon, Sirui Zhou, Dawn Waterworth, Cong Guo, George Davey Smith, Robert A. Scott, Claudia Langenberg, Lauren E. Mokry, J. Brent Richards, Philippe Sanseau, & Nicholas J. Wareham. (2019). Interleukin-18 as a drug repositioning opportunity for inflammatory bowel disease: A Mendelian randomization study. https://doi.org/10.1038/s41598-019-45747-2

Chicago

Luke Devey, Lon R. Cardon, Sirui Zhou, Dawn Waterworth, Cong Guo, George Davey Smith, Robert A. Scott, et al. 2019. “Interleukin-18 as a Drug Repositioning Opportunity for Inflammatory Bowel Disease: A Mendelian Randomization Study,” June. doi:10.1038/s41598-019-45747-2.